Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue for PTSD Extinction Learning
NCT01188694Phase 2Completed
- Sponsor
- University of Washington
- Start
- Sep 2009
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylene blue in post-traumatic stress disorder (PTSD), sponsored by University of Washington. Started Sep 2009; status: completed.
02
Drugs
methylene blue
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT01188694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01188694.